Sequoia Financial Advisors, LLC
Position in BHC — Bausch Health Companies Inc.
CIK 1599900
Akron, OH
Position in BHC
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$148,688
-$89,765 QoQ
Shares Held
30,160
-31.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#136
of 220 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Jun 30, 2026CallValue
$879,019
CallShares
178,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $18,226,773 across 16 Drug Manufacturers - Specialty & Generic names. BHC ranks #14 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
190,940 | $6,469,047 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
162,082 | $2,348,568 | |
| 3 | VTRS |
Viatris Inc
|
93,790 | $1,489,385 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
87,929 | $1,409,501 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,530 | $1,370,829 | |
| 6 | ZTS |
Zoetis Inc.
|
18,476 | $1,327,685 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,351 | $1,070,397 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
21,532 | $529,902 |
All Filings in BHC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $879,019 | 178,300 | Call | Sole | 2026-07-17 | |
| 2026-06-30 | $148,688 | 30,160 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $794,880 | 147,200 | Call | Sole | 2026-04-30 | |
| 2026-03-31 | $238,453 | 44,158 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $174,848 | 25,158 | Shares | Sole | 2026-02-03 | |
| 2025-12-31 | $312,750 | 45,000 | Call | Sole | 2026-02-03 | |
| 2025-09-30 | $129,000 | 20,000 | Call | Sole | 2025-10-29 | |
| 2025-09-30 | $155,819 | 24,158 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $134,252 | 20,158 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $130,422 | 20,158 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $162,473 | 20,158 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $164,489 | 20,158 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $140,501 | 20,158 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $213,876 | 20,158 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $161,955 | 20,194 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $165,994 | 20,194 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $161,264 | 20,158 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $177,009 | 21,853 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $141,733 | 22,569 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||